NYMX - ナイモックス・ファ―マシュ―ティカル （Nymox Pharmaceutical Corporation） ナイモックス・ファ―マシュ―ティカルNYMXのチャート
NYMXの企業情報
| symbol | NYMx |
|---|---|
| 会社名 | Nymox Pharmaceutical Corp. （ナイモックス・ファ―マシュ―ティカル） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Biotechnology: In Vitro_In Vivo Diagnostic Substances |
| 業種 | バイオテクノロジ―_メディカルリサ―チ 医療関連（Health Care） |
| 概要 | 事業概要 ニモックス・ファーマシューティカル(Nymox Pharmaceutical Corp)はカナダのバイオ医薬品会社である。同社は良性前立腺肥大症（BPH）の治療と低悪性度限局性前立腺癌治療薬候補NX-1207の開発を主とする。同社は高齢者向けの製品の研究・開発事業を通じて行う。同社はタバコ製品の使用を検出するために尿または唾液を使用するNicAlertおよびTobacAlert試験を販売している。同社はまた、販売されている製品、治験薬、その他の治療上・診断上の適応症の権利を所有する。また、アルツハイマー病の治療・予防のためのスタチン系薬剤の使用に関する権利を有する。子会社はNymox CorporationとSerex Incを含む。Nymox CorporationはNicAlertおよびTobacAlertの研究・開発を行い、Serex IncはNicAlertおよびTobacAlertの研究・開発・製造を行う。 ナイモックス・ファ―マシュ―ティカルは、カナダのバイオ医薬品会社。肥大前立腺、大腸菌、アルツハイマ―などの治療薬開発のほかに、タバコやアルツハイマ―およびその他障害向け診断薬の開発を手掛ける。主な製品は、尿によるアルツハイマ―病診断薬｢AlzheimAlert｣や、唾液によるニコチン検査薬｢ニコアラ―ト｣など。本社はケベック州セントロ―レンス。 Nymox Pharmaceutical Corporation specializes in the research and development of therapeutics and diagnostics, with a particular emphasis on products targeted for the unmet needs of the rapidly aging male population in developed economies. The Company's lead drug candidate for benign prostatic hyperplasia (BPH) Fexapotide Triflutate (FT) has completed Phase 3 development in more than 70 clinical centers in the United States, involving more than 1700 patients during the entire clinical development program. Currently, the Company will soon be filing for approval in major economies around the world, including the United States and Europe. |
| 本社所在地 | 9900 Cavendish Boulevard Suite 306 Saint-Laurent Quebec H4M 2V2 CAN |
| 代表者氏名 | ― |
| 代表者役職名 | ― |
| 電話番号 | ― |
| 設立年月日 | 34820 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | ―年 |
| 従業員数 | 24人 |
| url | www.nymox.com |
| nasdaq_url | https://www.nasdaq.com/symbol/nymx |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -12.95303 |
| 終値（lastsale） | 2.375 |
| 時価総額（marketcap） | 144264625 |
| 時価総額 | 時価総額（百万ドル） 96.42420 |
| 売上高 | 売上高（百万ドル） 0.37618 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 91.38420 |
| 当期純利益 | 当期純利益（百万ドル） -12.99294 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Nymox Pharmaceutical Corp revenues increased from $88K to $240K. Net loss decreased 8% to $5.1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects General_Administrative decrease from $647K (expense) to $455.8M (income) Research and development - Balancing val decrease from $1.8M (expense) to $454M (income). |
NYMXのテクニカル分析
NYMXのニュース
Nymox Pharmaceutical gets additional time to regain Nasdaq compliance 2023/03/15 13:50:15 Seeking Alpha
Nymox Pharmaceutical (NYMX) has been granted an additional period until July 3, 2023 to regain compliance with Nasdaq listing requirements. The firm expects to announce further…
Nymox Pharmaceutical Corporation (NYMX) can beat the pack with these strategies 2022/12/06 13:54:00 US Post News
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) closed Monday at $0.41 per share, up from $0.29 a day earlier. While Nymox Pharmaceutical Corporation has overperformed by 44.81%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, NYMX fell by -68.59%, with highs and lows ranging from $2.10 to $0.19, whereas […]
Glistening Stock’s Review: Nymox Pharmaceutical Corporation (NASDAQ:NYMX), Camber Energy, Inc. (AMEX:CEI) 2022/12/06 01:01:45 Stock Equity
Nymox Pharmaceutical Corporation (NYMX) with the stream of 44.81% also noticed, India Camber Energy, Inc. (CEI) encountered a rapid change of -5.04% in the last hour of Monday’s trading session. … The post Glistening Stock’s Review: Nymox Pharmaceutical Corporation (NASDAQ:NYMX), Camber Energy, Inc. (AMEX:CEI) appeared first on Stocks Equity .
Gold Down 1%; China Pharma Shares Spike Higher 2022/12/05 17:27:31 Benzinga
U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 200 points on Monday. The Dow traded down 0.63% to 34,214.25 while the NASDAQ fell 0.83% to 11,366.44. The S&P 500 also fell, dropping, 0.84% to 4,037.38. Also check this: Bitcoin Surpasses This Key Level; Axie Infinity Emerges As Top Gainer Leading and Lagging Sectors Communication services shares fell by just 0.1% on Monday. Leading the sector was strength from Loop Media Inc (NYSE: LPTV ) and Yalla Group Ltd - ADR (NYSE: YALA ). In trading on Monday, consumer discretionary shares dipped by 1.7%. Top Headline The ISM services index climbed to 56.5 in November from previous reading of 54.4. Equities Trading UP China Pharma Holdings, Inc. (NYSE: CPHI ) shares shot up 110% to $0.2369 after the company announced the acquisition of Dry Eye Disease Therapeutic Device Project. Shares of EHang Holdings Limited (NASDAQ: EH ) got a boost, shooting 19% to $6.83. EHang Holdings appointed Mr. Nick Ning Yang as a new director to the Company’s Board of Directors.
Nymox gets FDA feedback on NDA resubmission for lead asset 2022/09/13 13:55:00 Seeking Alpha
Nymox Pharmaceutical (NYMX), a biotech focused on drugs for the elderly, announced Tuesday that during the recent interactions, the FDA specified what additional information is required…
Nymox Pharmaceutical Corporation (NYMX) can beat the pack with these strategies 2022/12/06 13:54:00 US Post News
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) closed Monday at $0.41 per share, up from $0.29 a day earlier. While Nymox Pharmaceutical Corporation has overperformed by 44.81%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, NYMX fell by -68.59%, with highs and lows ranging from $2.10 to $0.19, whereas […]
Glistening Stock’s Review: Nymox Pharmaceutical Corporation (NASDAQ:NYMX), Camber Energy, Inc. (AMEX:CEI) 2022/12/06 01:01:45 Stock Equity
Nymox Pharmaceutical Corporation (NYMX) with the stream of 44.81% also noticed, India Camber Energy, Inc. (CEI) encountered a rapid change of -5.04% in the last hour of Monday’s trading session. … The post Glistening Stock’s Review: Nymox Pharmaceutical Corporation (NASDAQ:NYMX), Camber Energy, Inc. (AMEX:CEI) appeared first on Stocks Equity .
Gold Down 1%; China Pharma Shares Spike Higher 2022/12/05 17:27:31 Benzinga
U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 200 points on Monday. The Dow traded down 0.63% to 34,214.25 while the NASDAQ fell 0.83% to 11,366.44. The S&P 500 also fell, dropping, 0.84% to 4,037.38. Also check this: Bitcoin Surpasses This Key Level; Axie Infinity Emerges As Top Gainer Leading and Lagging Sectors Communication services shares fell by just 0.1% on Monday. Leading the sector was strength from Loop Media Inc (NYSE: LPTV ) and Yalla Group Ltd - ADR (NYSE: YALA ). In trading on Monday, consumer discretionary shares dipped by 1.7%. Top Headline The ISM services index climbed to 56.5 in November from previous reading of 54.4. Equities Trading UP China Pharma Holdings, Inc. (NYSE: CPHI ) shares shot up 110% to $0.2369 after the company announced the acquisition of Dry Eye Disease Therapeutic Device Project. Shares of EHang Holdings Limited (NASDAQ: EH ) got a boost, shooting 19% to $6.83. EHang Holdings appointed Mr. Nick Ning Yang as a new director to the Company’s Board of Directors.
Nymox gets FDA feedback on NDA resubmission for lead asset 2022/09/13 13:55:00 Seeking Alpha
Nymox Pharmaceutical (NYMX), a biotech focused on drugs for the elderly, announced Tuesday that during the recent interactions, the FDA specified what additional information is required…
Why Have Nymox Pharmaceutical Corporation (NASDAQ: NYMX) Shares Declined So Much? 2022/09/05 14:00:00 Stocks Register
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) price closed lower on Friday, September 02, dropping -4.32% below its previous close. A look at the daily price movement shows that the last close reads $0.38, with intraday deals fluctuated between $0.3125 and $0.3917. The company’s 5Y monthly beta was ticking 1.00. Taking into account the 52-week price action we … Why Have Nymox Pharmaceutical Corporation (NASDAQ: NYMX) Shares Declined So Much? Read More »
Nymox Pharmaceutical Corporation (NYMX) can beat the pack with these strategies 2022/12/06 13:54:00 US Post News
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) closed Monday at $0.41 per share, up from $0.29 a day earlier. While Nymox Pharmaceutical Corporation has overperformed by 44.81%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, NYMX fell by -68.59%, with highs and lows ranging from $2.10 to $0.19, whereas […]
Glistening Stock’s Review: Nymox Pharmaceutical Corporation (NASDAQ:NYMX), Camber Energy, Inc. (AMEX:CEI) 2022/12/06 01:01:45 Stock Equity
Nymox Pharmaceutical Corporation (NYMX) with the stream of 44.81% also noticed, India Camber Energy, Inc. (CEI) encountered a rapid change of -5.04% in the last hour of Monday’s trading session. … The post Glistening Stock’s Review: Nymox Pharmaceutical Corporation (NASDAQ:NYMX), Camber Energy, Inc. (AMEX:CEI) appeared first on Stocks Equity .
Gold Down 1%; China Pharma Shares Spike Higher 2022/12/05 17:27:31 Benzinga
U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 200 points on Monday. The Dow traded down 0.63% to 34,214.25 while the NASDAQ fell 0.83% to 11,366.44. The S&P 500 also fell, dropping, 0.84% to 4,037.38. Also check this: Bitcoin Surpasses This Key Level; Axie Infinity Emerges As Top Gainer Leading and Lagging Sectors Communication services shares fell by just 0.1% on Monday. Leading the sector was strength from Loop Media Inc (NYSE: LPTV ) and Yalla Group Ltd - ADR (NYSE: YALA ). In trading on Monday, consumer discretionary shares dipped by 1.7%. Top Headline The ISM services index climbed to 56.5 in November from previous reading of 54.4. Equities Trading UP China Pharma Holdings, Inc. (NYSE: CPHI ) shares shot up 110% to $0.2369 after the company announced the acquisition of Dry Eye Disease Therapeutic Device Project. Shares of EHang Holdings Limited (NASDAQ: EH ) got a boost, shooting 19% to $6.83. EHang Holdings appointed Mr. Nick Ning Yang as a new director to the Company’s Board of Directors.
Nymox gets FDA feedback on NDA resubmission for lead asset 2022/09/13 13:55:00 Seeking Alpha
Nymox Pharmaceutical (NYMX), a biotech focused on drugs for the elderly, announced Tuesday that during the recent interactions, the FDA specified what additional information is required…
Why Have Nymox Pharmaceutical Corporation (NASDAQ: NYMX) Shares Declined So Much? 2022/09/05 14:00:00 Stocks Register
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) price closed lower on Friday, September 02, dropping -4.32% below its previous close. A look at the daily price movement shows that the last close reads $0.38, with intraday deals fluctuated between $0.3125 and $0.3917. The company’s 5Y monthly beta was ticking 1.00. Taking into account the 52-week price action we … Why Have Nymox Pharmaceutical Corporation (NASDAQ: NYMX) Shares Declined So Much? Read More »